Matt Sagan: Cancer therapeutic vaccines can become a new breakthrough
Matt Sagan, Co-Founder and CEO of FiBioMed, reshared a post on X by The Economist adding:
“Cancer therapeutic vaccines can become a new breakthrough in treating cancers.
After decades of research, small wins, and failures, we’re getting close to the point where the first vaccines can become a real novel safe treatment option for many patients.
Fingers crossed for all the teams around the world working in the field of cancer vaccines.
We need to deliver several platforms and solutions, from mRNA to VLPs to create the whole cancer vaccines pipeline and share ideas, experiences, and failures to make it happen.”
Quoting The Economist’s post:
“Will there be a vaccine for cancer in 2025?
Artificial intelligence and mRNA technology, developed during the COVID-19 pandemic, are making some scientists hopeful of a breakthrough, as our health editor, Natasha Loder, explains.
Proceed to the video attached to the post.
More posts featuring Matt Sagan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023